Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) Sees Large Drop in Short Interest

Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL - Get Free Report) was the target of a significant drop in short interest in the month of December. As of December 15th, there was short interest totalling 19,000 shares, a drop of 5.9% from the November 30th total of 20,200 shares. Currently, 0.6% of the company's stock are sold short. Based on an average daily trading volume, of 19,600 shares, the days-to-cover ratio is currently 1.0 days.

Hedge Funds Weigh In On Cryo-Cell International

A hedge fund recently raised its stake in Cryo-Cell International stock. Geode Capital Management LLC boosted its holdings in Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL - Free Report) by 68.5% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 39,860 shares of the company's stock after acquiring an additional 16,203 shares during the quarter. Geode Capital Management LLC owned 0.49% of Cryo-Cell International worth $254,000 at the end of the most recent quarter. 10.44% of the stock is owned by institutional investors.

Cryo-Cell International Price Performance

NYSEAMERICAN CCEL traded up $0.01 during trading hours on Wednesday, reaching $7.41. 9,303 shares of the company's stock traded hands, compared to its average volume of 11,188. Cryo-Cell International has a 52-week low of $4.47 and a 52-week high of $9.50. The stock has a market cap of $59.72 million, a P/E ratio of -6.99 and a beta of 0.49.

Cryo-Cell International (NYSEAMERICAN:CCEL - Get Free Report) last issued its quarterly earnings results on Tuesday, October 15th. The company reported $0.13 EPS for the quarter, topping analysts' consensus estimates of $0.02 by $0.11. The firm had revenue of $8.07 million for the quarter. Cryo-Cell International had a negative return on equity of 42.06% and a negative net margin of 28.03%.

Cryo-Cell International Announces Dividend

The business also recently declared a -- dividend, which was paid on Friday, November 29th. Stockholders of record on Friday, November 15th were issued a dividend of $0.25 per share. The ex-dividend date was Friday, November 15th. Cryo-Cell International's payout ratio is presently -94.34%.

Cryo-Cell International Company Profile

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.